Physician profile
Bart De Gregorio
NPI 1245205558
$3,163.56
in general payments reported to CMS, 2019-2025
13 companies · $275 in 2025
The $275 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $88.68 · 2021: $286 · 2022: $726 · 2023: $728 · 2024: $774 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,778.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,777.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $1,123.08 | 2022-2025 | Barostim Neo System |
| Boston Scientific Corporation | $602.21 | 2019-2025 | Watchman Flx, Cds - Mct/Cem Monitoring |
| Abbott Laboratories | $375.65 | 2019-2024 | Aveir |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $321.45 | 2021-2024 | Lifevest |
| Medtronic, INC. | $210.41 | 2021-2025 | Hawkone, Symplicity G3 |
| Pfizer INC. | $193.52 | 2019-2025 | |
| Amgen INC. | $91.96 | 2024 | Repatha |
| Cardiva Medical, INC. | $53.38 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $53.19 | 2019-2024 | |
| Itamar Medical INC | $49.07 | 2023 | Watchpatone |
| Heartflow, INC. | $43.89 | 2025 | |
| Medtronic Vascular, INC. | $29.09 | 2019 | |
| Vivaquant INC, Dba Rhythm Express | $16.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bart De Gregorio listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.